Cargando…

Letter regarding “Non-alcoholic fatty liver disease: Definition and subtypes”

Detalles Bibliográficos
Autores principales:	Jeong, Seogsong, Lim, Yohwan, Lee, Su Kyoung, Han, Hyun Wook
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association for the Study of the Liver 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366794/ https://www.ncbi.nlm.nih.gov/pubmed/37157774 http://dx.doi.org/10.3350/cmh.2023.0129

Ejemplares similares

Correspondence on Letter regarding “Non-alcoholic fatty liver disease: Definition and subtypes”
por: Han, Seul Ki, et al.
Publicado: (2023)

Non-alcoholic fatty liver disease and risk of dementia: Unmet need for a pooled analysis of cohort studies
por: Jeong, Seogsong, et al.
Publicado: (2022)

Letter regarding “Risk factors in nonalcoholic fatty liver disease”
por: Pratap, Abhijit, et al.
Publicado: (2023)

Correspondence on Letter regarding “The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults”
por: Lee, Jun-Hyuk, et al.
Publicado: (2023)

Non-alcoholic fatty liver disease: Definition and subtypes
por: Han, Seul Ki, et al.
Publicado: (2023)

Letter regarding “The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults”
por: Lee, Hye Won
Publicado: (2023)

Development and validation of a nonalcoholic fatty liver disease-based self-diagnosis tool for diabetes
por: Kim, Hye Jun, et al.
Publicado: (2022)

Association of Physical Activity With SARS-CoV-2 Infection and Severe Clinical Outcomes Among Patients in South Korea
por: Lim, YoHwan, et al.
Publicado: (2023)

Letter regarding “Evidence-based hyponatremia management in liver disease”
por: Theodorou, Daphne J., et al.
Publicado: (2023)

Letter regarding “Association of liver abnormalities with in-hospital mortality in patients with COVID-19”
por: Luo, Meng-Si, et al.
Publicado: (2021)

Letter regarding “Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways”
por: Liu, Yuanbin, et al.
Publicado: (2023)

A Response to: Letter to the Editor Regarding “Determining the Definitive Time Criterion for Postherpetic Neuralgia Using Infrared Thermographic Imaging”
por: Han, Woong Ki, et al.
Publicado: (2022)

Letter to the Editor Regarding Vaping Article
por: Spitz, Rabbi Yehuda
Publicado: (2019)

Correspondence on Letter regarding “Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways”
por: Lee, Seung Min, et al.
Publicado: (2023)

Body Composition and Non-alcoholic Fatty Liver Disease
por: Abenavoli, Ludovico, et al.
Publicado: (2016)

Letter regarding “Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?”
por: Emiroglu, Halil Haldun
Publicado: (2023)

Regarding the letter from Roxburgh, et al.
por: Gross, RH, et al.
Publicado: (2020)

The Asia Pacific Pediatric Association (APPA) position statement on the MAFLD definition of fatty liver disease
por: Memon, Iqbal A., et al.
Publicado: (2023)

Eyeing non-alcoholic fatty liver disease: The noninvasive way
por: Gude, Dilip
Publicado: (2011)

Silymarin: An option to treat non-alcoholic fatty liver disease
por: Colica, Carmela, et al.
Publicado: (2017)

Letter to the Editor: Regarding COVID-19 in Children with Asthma
por: Özdemir, Öner
Publicado: (2021)

Letter regarding “ACVIM consensus statement on pancreatitis in cats”
por: Kook, Peter, et al.
Publicado: (2021)

Letter regarding "ACVIM consensus statement on pancreatitis in cats"
por: Törner, Katrin, et al.
Publicado: (2021)

Letter to the editor regarding the article of Chen et al.
por: Islamoglu, Mehmet Sami, et al.
Publicado: (2022)

Letter to the Editor Regarding “Ultrasound Features of Adhesive Capsulitis”
por: Boudier-Revéret, Mathieu, et al.
Publicado: (2022)

Letter to the editor regarding “Selfies: A boon or bane?”
por: Kazerooni, Rashid
Publicado: (2022)

Letter to the Editor Regarding: Evolving Business Models in Orthotics
por: Laakso, L.
Publicado: (2022)

Letter to the editor regarding “unusual extraneural metastasis of glioblastoma”
por: Waack, Andrew Leland, et al.
Publicado: (2023)

Letter to Editor regarding “Unusual Presentation of Spontaneous Chylothorax”
por: Varghese, Anjali Rachel, et al.
Publicado: (2022)

Response letter: Letter to the editor regarding Wei W et al.: ‘‘Experience of the Hubei cancer hospital in Wuhan, China”
por: Bi, Jianping, et al.
Publicado: (2021)

Letter regarding “COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis”
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

Letter to Editor Regarding the OCEAN Study [Letter]
por: Yawn, Barbara P, et al.
Publicado: (2021)

Letter to the Editor Regarding “Letter to the Editor: Spinal and Neurosurgical Publications During the COVID-19 Era”
por: Akhaddar, Ali, et al.
Publicado: (2020)

Lean non-alcoholic fatty liver disease: do not forget diabetes
por: Patoulias, Dimitrios Ioannis, et al.
Publicado: (2019)

Noninvasive Imaging for the Evaluation of Non-Alcoholic Fatty Liver Disease Spectrum
por: Liu, Qianjiao, et al.
Publicado: (2021)

Non-alcoholic fatty liver disease, diabetes medications and blood pressure
por: Ilias, Ioannis, et al.
Publicado: (2021)

GOLD or lower limit of normal definition? a letter and authors’ response
por: Quanjer, Philip, et al.
Publicado: (2012)

Correspondence on Letter regarding “COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis”
por: Cheung, Ka Shing, et al.
Publicado: (2023)

Letter Regarding Article, "Biventricular Takotsubo Cardiomyopathy Associated with Epilepsy"
por: Madias, John E.
Publicado: (2016)

Response to letter regarding “ACVIM consensus statement on pancreatitis in cats”
por: Forman, Marnin A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ca8ecea3jfn9c22o8a7t4qlb2a